Earnings Outlook For Iterum Therapeutics
Portfolio Pulse from Benzinga Insights
Iterum Therapeutics (NASDAQ:ITRM) is expected to release its quarterly earnings report on Tuesday, 2023-11-14, with analysts predicting an EPS of $-0.91. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Iterum's stock price has shown varied reactions to past earnings results. The stock is currently trading at $0.79, down 47.29% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
November 13, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Iterum Therapeutics is anticipated to report a quarterly EPS of $-0.91 and investors are hopeful for a beat and positive future guidance. The stock has declined 47.29% over the past year, indicating bearish sentiment.
The expected EPS of $-0.91 sets a cautious tone for Iterum Therapeutics' earnings report. While an earnings beat and positive guidance could provide a short-term boost, the stock's significant decline over the past year reflects a bearish long-term sentiment that may temper any positive reaction. The historical price changes post-earnings have been mixed, making it challenging to predict the short-term impact with high confidence.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100